Besides the metabolic regulation of adiponectin in this group of COPD, Watz et al. reported that in COPD patients, the presence of metabolic syndrome is associated with an increased inflammatory profile; this coexistence would suggest a role for adiponectin in the regulation of both inflammation and body composition [64]. This evidence concerns the gene ADIPOQ and chronic obstructive pulmonary disease.